Editorial: Skin Blistering Diseases
Cristina Has +4 more
doaj +1 more source
Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid in an Elderly Woman With Type 2 Diabetes Mellitus: A Case Report. [PDF]
Roa Alvarez G +4 more
europepmc +1 more source
Peristomal bullous pemphigoid: expanding the spectrum of localized presentations. [PDF]
Ramírez-Bravo F +5 more
europepmc +1 more source
Dupilumab for Treatment-refractory Bullous Pemphigoid: A Case Series of Six Patients. [PDF]
Skovsgård CH +4 more
europepmc +1 more source
A Rare Case of Anti-Integrin β4 IgG-Positive Bullous Pemphigoid Lacking Mucosal Lesions. [PDF]
Liu J +7 more
europepmc +1 more source
Lichenoid variant of paraneoplastic pemphigus arising 1 week after thymoma resection. [PDF]
Wang Y, Wang Y, Zhang L, Liu Q, Wang X.
europepmc +1 more source
Durable Complete Response Following Nivolumab Discontinuation in Human Papillomavirus (HPV)-Positive Oropharyngeal Carcinoma Complicated by Bullous Pemphigoid: A Case Report. [PDF]
Abreu M +3 more
europepmc +1 more source
Clinical Characterization and Outcomes of Dupilumab for Pemphigoid Gestationis: A Case Series of Five Patients and Literature Review. [PDF]
Meijer JM +11 more
europepmc +1 more source
Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab. [PDF]
Yu L +5 more
europepmc +1 more source
Bullous Pemphigoid: A Focused Review on Antigen Epitopes. [PDF]
Li J, Feng X, Zou M, Wei M, Li W.
europepmc +1 more source

